GLADSTONE AIREWELE to Adolescent
This is a "connection" page, showing publications GLADSTONE AIREWELE has written about Adolescent.
Connection Strength
0.215
-
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043). Br J Haematol. 2011 Apr; 153(1):92-104.
Score: 0.026
-
Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatr Blood Cancer. 2009 Dec; 53(6):1060-3.
Score: 0.024
-
Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department. Pediatr Blood Cancer. 2024 Oct; 71(10):e31222.
Score: 0.016
-
Hospital acquired venous thromboembolism in children with sickle cell disease. Pediatr Hematol Oncol. 2024 Oct; 41(7):459-469.
Score: 0.016
-
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. Trials. 2023 Aug 17; 24(1):538.
Score: 0.015
-
Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol. 2001 Jan; 20(1):75-86.
Score: 0.013
-
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Am J Hematol. 2020 09; 95(9):E242-E244.
Score: 0.012
-
Incidental findings on brain magnetic resonance imaging of children with sickle cell disease. Pediatrics. 2010 Jul; 126(1):53-61.
Score: 0.012
-
Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst. 1998 Apr 01; 90(7):543-4.
Score: 0.011
-
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL? Sickle Cell Disease Module. Health Qual Life Outcomes. 2017 Jun 12; 15(1):124.
Score: 0.010
-
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood. 2015 Oct 01; 126(14):1651-7.
Score: 0.009
-
Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi-Center Clinical Trial cohort. Am J Hematol. 2015 Jan; 90(1):2-7.
Score: 0.008
-
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014 Aug 21; 371(8):699-710.
Score: 0.008
-
Tuberculosis in pediatric oncology and bone marrow transplantation patients. Pediatr Blood Cancer. 2014 Aug; 61(8):1484-5.
Score: 0.008
-
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood. 2012 Apr 19; 119(16):3684-90.
Score: 0.007
-
Improving care for children with sickle cell disease/acute chest syndrome. Pediatrics. 2011 Feb; 127(2):e480-8.
Score: 0.006
-
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010 Jun; 11(6):543-52.
Score: 0.006
-
Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2491-5.
Score: 0.005